Doç. Dr. ADEM ŞAHİN

Yayın Ağı

Makaleler 24

1. FDA original new drug approvals in the first quarter of 2025

Ertan-Ahmed S., Çapan Y., Şahin A.

European Journal of Life Sciences , cilt.4, sa.2, ss.94-105, 2025 (Hakemli Dergi)

2. Latest developments in small molecule analgesics: heterocyclic scaffolds II

EVREN A. E., HIDIR A., Kurban B., Özkan B. N. S., LEVENT S., ŞAHİN A., et al.

Future Medicinal Chemistry , cilt.17, sa.19, ss.2391-2405, 2025 (SCI-Expanded, Scopus)

3. ICP-MS Method for Simultaneous Determination of Aluminum, Sodium, and Potassium in Human Albumin Solution for Infusion

Gundogdu S. O., Aytimur Y., Turhan S., ŞAHİN A.

International Journal of Analytical Chemistry , cilt.2025, sa.1, 2025 (SCI-Expanded, Scopus)

4. An all-in-one nanoparticle for overcoming drug resistance: doxorubicin and elacridar co-loaded folate receptor targeted PLGA/MSN hybrid nanoparticles.

Tonbul H., Şahin A., Öztürk S. C., Ultav G., Tavukçuoğlu E., Akbaş S., et al.

Journal of drug targeting , cilt.32, sa.9, ss.1101-1110, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

5. Development and In Vitro Evaluation of Quercetin Loaded Folic Acid Conjugated PLGA Nanoparticles for the Treatment of Breast Cancer

Çetiner K., Seko I., Ulutürk S., Gür B., Şahin A., Çapan Y.

ACTA FARMACEUTICA BONAERENSE , cilt.43, sa.10, ss.2177-2183, 2024 (SCI-Expanded)

6. DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR DETERMINATION OF ELEMENTAL IMPURITIES IN MICAFUNGIN FOR INJECTION

Gundogdu S. O., Turhan S., Babacanoglu A. O., Catak T., ŞAHİN A.

Acta Poloniae Pharmaceutica - Drug Research , cilt.81, sa.2, ss.279-286, 2024 (SCI-Expanded, Scopus)

7. Thermosensitive gel of pomegranate peel extract as alternative for the treatment of local infections

ŞAHİN A., GÜL Ü. D., Bayazit G., KAYNAK M. S.

Acta Pharmaceutica Sciencia , cilt.62, sa.3, ss.647-659, 2024 (Scopus)

8. Targeted siRNA lipid nanoparticles for the treatment of KRAS-mutant tumors

Anthiya S., ÖZTÜRK S. C., Yanik H., Tavukcuoglu E., ŞAHİN A., Datta D., et al.

Journal of Controlled Release , cilt.357, ss.67-83, 2023 (SCI-Expanded, Scopus)

9. Comparative evaluation of lyophilized voriconazole formulations marketed in European Union

ŞAHİN A., Çilingiroğlu G. Y., Çatak T., Ulusoy S., GÜL Ü. D., Gündoğdu S. Ö.

Journal of Research in Pharmacy , cilt.27, sa.1, ss.120-129, 2023 (ESCI, Scopus, TRDizin)

10. Silica nanoparticle synthesis by experimental design for drug and gene delivery applications

Ultav G., TONBUL H., ŞAHİN A., ÇAPAN Y.

Journal of Research in Pharmacy , cilt.27, sa.1, ss.12-22, 2023 (Scopus, TRDizin)

11. Intraperitoneal administration of PLGA nanoparticles could deliver the cargo to tumor-associated macrophages with less spreading peritoneal macrophages in the treatment of peritoneal carcinomatosis

ŞAHİN A., ÖZTÜRK S. C.

Journal of Drug Delivery Science and Technology , cilt.77, 2022 (SCI-Expanded, Scopus)

12. Evaluation of burn wound healing activity of thermosensitive gel and PLGA nanoparticle formulation of quercetin in Wistar albino rats

Cetin N., Menevse E., Celik Z. E., Ceylan C., Rama S. T., Gultekin Y., et al.

Journal of Drug Delivery Science and Technology , cilt.75, 2022 (SCI-Expanded, Scopus)

13. Development of curcumin and docetaxel co-loaded actively targeted PLGA nanoparticles to overcome blood brain barrier

Seko I., TONBUL H., Tavukcuoglu E., Sahin A., Akbas S., Yanik H., et al.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.66, 2021 (SCI-Expanded, Scopus)

14. Folic acid decoration of mesoporous silica nanoparticles to increase cellular uptake and cytotoxic activity of doxorubicin in human breast cancer cells

TONBUL H., Sahin A., Tavukcuoglu E., Ultav G., AKBAŞ S., AKTAŞ Y., et al.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.63, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

15. pH-sensitive chitosan-PEG-decorated hollow mesoporous silica nanoparticles could be an effective treatment for acute myeloid leukemia (AML)

Ultav G., TONBUL H., Tavukcuoglu E., ÖZTÜRK S., Akbas S., Sahin A., et al.

Journal of Nanoparticle Research , cilt.24, sa.2, 2021 (SCI-Expanded, Scopus)

16. Combination of Paclitaxel and R-flurbiprofen loaded PLGA nanoparticles suppresses glioblastoma growth on systemic administration

Caban-Toktas S., Sahin A., Lule S., Esendagli G., Vural I., Karlı Oguz K., et al.

International Journal of Pharmaceutics , cilt.578, 2020 (SCI-Expanded, Scopus)

17. Combination drug delivery with actively-targeted PLGA nanoparticles to overcome multidrug resistance in breast cancer

Tonbul H., Sahin A., Tavukcuoglu E., ESENDAĞLI G., ÇAPAN Y.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.54, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

18. Characterization of bevacizumab by dynamic light scattering while maintaining its native structure

Akbas S., Sahin A., ÇALIŞ S., Oncel H., ÇAPAN Y.

PHARMAZIE , cilt.73, sa.7, ss.369-374, 2018 (SCI-Expanded, Scopus)

19. Development and in vitro evaluation of doxorubicin and celecoxib co-loaded bone targeted nanoparticles

Kozlu S., Sahin A., Ultav G., Yerlikaya F., ÇALIŞ S., ÇAPAN Y.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.45, ss.213-219, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

20. Design and in vitro evaluation of tenofovir-loaded vaginal gels for the prevention of HIV infections

TİMUR S. S., ŞAHİN A., AYTEKİN E., ÖZTÜRK N., Polat K. H., Tezel N., et al.

Pharmaceutical Development and Technology , cilt.23, sa.3, ss.301-310, 2018 (SCI-Expanded, Scopus)

21. Development and validation of a LC-FL method for the simultaneous determination of doxorubicin and celecoxib in nanoparticulate fixed dose combination (NanoFDC)

Kozlu S., ŞAHİN A., ÇALIŞ S., ÇAPAN Y.

PHARMAZIE , cilt.72, sa.10, ss.568-570, 2017 (SCI-Expanded, Scopus)

22. Evaluation of brain-targeted chitosan nanoparticles through blood-brain barrier cerebral microvessel endothelial cells

Sahin A., Yoyen-Ermis D., Caban-Toktas S., Horzum U., AKTAŞ Y., Couvreur P., et al.

JOURNAL OF MICROENCAPSULATION , cilt.34, sa.7, ss.659-666, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

23. A small variation in average particle size of PLGA nanoparticles prepared by nanoprecipitation leads to considerable change in nanoparticles' characteristics and efficacy of intracellular delivery

ŞAHİN A., ESENDAĞLI G., YERLİKAYA F., Caban-Toktas S., Yoyen-Ermis D., HORZUM U., et al.

ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY , cilt.45, sa.8, ss.1657-1664, 2017 (SCI-Expanded, Scopus)

24. Using PVA and TPGS as combined emulsifier in nanoprecipitation method improves characteristics and anticancer activity of ibuprofen loaded PLGA nanoparticles

Sahin A., Spiroux F., Guedon I., Arslan F., Sarcan E., Ozkan T., et al.

Pharmazie , cilt.72, sa.9, ss.525-528, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 32

1. DEVELOPMENT OF PASTILLES CONTAINING POMEGRANATE PEEL EXTRACT

ŞAHİN A.

6th INTERNATIONAL HEALTH SCIENCE AND LIFE CONGRESS, Burdur, Türkiye, 2 - 05 Mart 2023, cilt.442, (Özet Bildiri)

2. CNT-02 is a potent candidate drug for the elimination of lung damage caused by COVID-19

Yağ Çilingiroğlu G., Çatak T., Karasu İ., Ulusoy S., Özlem Gündoğdu S., ŞAHİN A.

11th International Drug Chemistry Congress, 09 Mart 2023, (Özet Bildiri)

3. Evaluation of pomegranate peel extract and its thermosensitive gel formulation for the treatment of oral infections

ŞAHİN A., BAYAZIT G., GÜL Ü. D.

5th International Eurasian Conference on Biological and Chemical Sciences (EurasianBioChem 2022), Ankara, Türkiye, 23 - 25 Kasım 2022, ss.444, (Özet Bildiri)

4. IN VIVO EVALUATION OF DOXORUBICIN AND ELACRIDAR CO-LOADED PLGA/SILICA HYBRID NANOPARTICLES AGAINST MULTIDRUG RESISTANT BREAST CANCER

TONBUL H., ŞAHİN A., ÖZTÜRK S. C., ULTAV G., ESENDAĞLI G., ÇAPAN Y.

9th BBBB International Conference on Pharmaceutical Sciences, Ljubljana, Slovenya, 15 - 17 Eylül 2022, ss.79-80, (Özet Bildiri)

5. CRITICAL STEPS OF SOLUTION PREPARATION PROCESS FOR PARENTERAL DRUGS: TIGECYCLINE CASE

ŞAHİN A.

The Sixth International Symposium on Pharmaceutical and Biomedical Sciences, Gaziantep, Türkiye, 26 - 28 Mayıs 2022, ss.72, (Özet Bildiri)

6. PRODUCTION OF MELOXICAM NANOCRYSTALS BY NANOPRECIPITATION METHOD

ŞAHİN A., TONBUL H.

The Sixth International Symposium on Pharmaceutical and Biomedical Sciences, Gaziantep, Türkiye, 26 - 28 Mayıs 2022, ss.73, (Özet Bildiri)

7. Bevacizumab loaded nanocapsules: cytotoxicity and internalization in lung and pancreatic cancer spheroids

Fernandez-Marino I., Tavukçuoğlu E., Yanık H., ŞAHİN A., ESENDAĞLI G., Crecente-Campo J., et al.

XIIIth Spanish-Portuguese Conference on Controlled Drug Delivery, 24 Ocak 2020, (Özet Bildiri)

8. PREPARATION OF PLGA NANOPARTICLES WITH DIFFERENT SURFACTANTS AS DRUG DELIVERY SYSTEM

TONBUL H., ŞAHİN A.

GEVHER NESİBE4. ULUSLARARASI SAĞLIK BİLİMLERİ KONGRESİ, Ankara, Türkiye, 22 - 23 Kasım 2019, ss.1-3, (Tam Metin Bildiri)

9. FOLIC ACID CONJUGATED MESOPOROUS SILICA NANOPARTICLES FOR ENHANCED THERAPEUTIC EFFICACY OF DOXORUBICIN IN BREAST CANCER

TONBUL H., ULTAV G., AKBAŞ S., ŞAHİN A., TAVUKÇUOĞLU E., AKTAŞ Y., et al.

8th BBBB Conference on Pharmaceutical Sciences, 14 - 16 Ekim 2019, (Tam Metin Bildiri)

10. PREPARATION OF ACTIVE TARGETED POLY(LACTİC-CO-GLYCOLIC ACID) NANOPARTICLES WITH OLEYL CYSTEINEAMIDE

AKBAŞ S., ULTAV G., ŞAHİN A., TAVUKÇUOĞLU E., TONBUL H., ESENDAĞLI G., et al.

8th BBBB Conference on Pharmaceutical Sciences, 14 - 16 Ekim 2019, (Tam Metin Bildiri)

11. REVERSAL OF DRUG RESISTANCE IN EMT6/AR1 CELL LINE BY A CHEMİCAL MODULATOR: ELACRIDAR

TONBUL H., AKBAŞ S., ULTAV G., ŞAHİN A., ÇAPAN Y.

International Multidisciplinary Symposium on Drug Research and Development (DRD)-2019, 1 - 03 Temmuz 2019, (Tam Metin Bildiri)

12. GX-G3, a long-acting G-CSF, compared with pegfilgrastim in reducing duration of severe neutropenia after chemotherapy for non-Hodgkin’s lymphoma.

Ertan-Ahmed S., Kiehl M. G., Radinoff A., Graklanov V., Tzvetkov N., Mihăescu R., et al.

2019 ASCO Annual Meeting I, 31 Mayıs 2019, (Özet Bildiri)

13. Preperation, Characterization, Cytotoxicity Evaluations of Folic Acid Conjugated Mezoporous Silica Nanoparticles

TONBUL H., ULTAV G., AKBAŞ S., ŞAHİN A., Tavukçuoğlu E., ESENDAĞLI G., et al.

19th International Pharmaceutical Technology Symposium-IPTS 2018, 17 Eylül 2018, (Özet Bildiri)

14. A COMPERISON OF PLGA NANOPARTICLE PREPARATION METHODS FOR BEVACIZUMAB ENCAPSULATION

AKBAŞ S., ULTAV G., TONBUL H., ŞAHİN A., ÇAPAN Y.

12th International Symposium on Pharmaceutical Sciences (ISOPS), 26 - 29 Haziran 2018, (Özet Bildiri)

15. IN VITRO EVALUATION OF PACLITAXEL LOADED MESOPOROUS SILICA NANOPARTICLES

TONBUL H., AKBAŞ S., ULTAV G., ŞAHİN A., AKTAŞ Y., ÇAPAN Y.

EUFEPS Annual Meeting 2018, 24 - 26 Mayıs 2018, (Özet Bildiri)

16. DEVELOPMET AND EVALUATION OF SILICA NANOPARTICLES USING A QUALITY BY DESIGN APPROACH

TONBUL H., AKBAŞ S., ULTAV G., ŞAHİN A., AKTAŞ Y., ÇAPAN Y.

EUFEPS Annual Meeting 2018, 24 - 26 Mayıs 2018, (Özet Bildiri)

17. Synthesis and Characterization of Silica Nanoparticles: Obtaining nanoparticles smaller than 100 nm

TONBUL H., AKBAŞ S., ULTAV G., ŞAHİN A., KAYNAK M. S., AKTAŞ Y., et al.

2nd International Gazi Symposium Series, 11 - 13 Ekim 2017, (Özet Bildiri)

18. DEVELOPMENT AND IN VITRO EVALUATION OF PH TRIGGERED HOLLOW SILICA NANOPARTICLES AS A DRUG DELIVERY SYSTEM

ULTAV G., AKBAŞ S., TONBUL H., ŞAHİN A., ÇAPAN Y.

2nd International Gazi Pharma Symposium Series (GPSS-2017), 11 - 13 Ekim 2017, (Özet Bildiri)

19. CHARACTERIZATION OF BEVACIZUMAB BY DYNAMIC LIGHTSCATTERING TECHNIQUE

AKBAŞ S., ULTAV G., TONBUL H., ŞAHİN A., ÇAPAN Y.

2nd International Gazi Symposium Series, 11 - 13 Ekim 2017, (Özet Bildiri)

20. Transferrine hedeflendirilmiş paklitaksel yüklü PLGA nanopartiküllerinin meme kanserindeki etkinliği

TONBUL H., ŞAHİN A., ÖZTÜRK N., VURAL İ., KAYNAK M. S., ÇAPAN Y.

1. Anadolu Üniversitesi Eczacılık Fakültesi Sempozyumu (ANES), Türkiye, 1 Haziran - 02 Ocak 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

21. Comparing Intracellular Delivery of PLGA and Chitosan Nanoparticles: Lessons and Challenges

ŞAHİN A., YERLİKAYA F., AKTAŞ Y., ESENDAĞLI G., ÇAPAN Y.

GPEN 2016, Kansas, Amerika Birleşik Devletleri, 9 - 12 Kasım 2016

22. Intracellular delivery and intraperıtoneal retention of different sized PLGA nanoparticles prepared by nanoprecipitation method

ŞAHİN A., ESENDAĞLI G., YERLİKAYA F., KOZLU S., YÖYEN ERMİŞ D., Horzum U., et al.

18th International Pharmaceutical Technology Symposium-IPTS 2016, 18 Eylül 2016, (Özet Bildiri)

23. Co-Encapsulation Studies of Doxorubicin andCelecoxib in PLGA Nanoparticles

KOZLU S., ŞAHİN A., Şahan S., YERLİKAYA F., ÇAPAN Y.

18th International Pharmaceutical Technology Symposium-IPTS 2016, 18 Eylül 2016, (Özet Bildiri)

24. Development and in vitro evaluation of transferrin targeted PLGA nanoparticle

TONBUL H., ŞAHİN A., KAYNAK M. S., ÇAPAN Y.

18th International Pharmaceutical Technology Symposium-IPTS 2016, 18 Eylül 2016, (Özet Bildiri)

25. PREPARATION AND IN VITRO EVALUATION OF ZICONOTIDE LOADED PLGA AND CHITOSAN NANOPARTICLES

ŞAHİN A., TOKTAŞ S., AKTAŞ Y., ÇAPAN Y.

Barcelona BioMed Conference Blood Brain Barrier, Barselona, İspanya, 2 - 04 Kasım 2015, (Özet Bildiri)

26. Effects of Combined Surfactants in the Formulation of Docetaxel-Loaded PLGA Nanoparticles

Abdykerim Kyzy G., TOKTAŞ S., ŞAHİN A., ÇAPAN Y.

American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition 2015, 25 - 29 Ekim 2015, (Özet Bildiri)

27. Determination of Critical Parameters of Paclitaxel and Flurbiprofen Co-Loaded PLGA Nanoparticles Prepared by Nanoprecipitation

ŞAHİN A., TOKTAŞ S., Abdykerim Kyzy G., YERLİKAYA F., AKTAŞ Y., ÇAPAN Y.

American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition 2015, 25 - 29 Ekim 2015, (Özet Bildiri)

28. In Vitro and In Vivo Evaluation of Paclitaxel and R-Flurbiprofen Loaded Chitosan Coated PLGA Nanoparticles

TOKTAŞ S., LÜLE S., ŞAHİN A., KARA A., PEHLİVAN S., VURAL İ., et al.

American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition 2015, 25 - 29 Ekim 2015, (Özet Bildiri)

29. Particle Size Optimization of Ibuprofen Loaded PLGA Nanoparticles Using Box–Behnken Design

ŞAHİN A., TOKTAŞ S., AKTAŞ Y., ÇAPAN Y.

American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition 2015, 25 - 29 Ekim 2015, (Özet Bildiri)

30. Formulation and In Vitro Evaluation of Nanoparticles Containing Docetaxel

Babat D., TOKTAŞ S., ŞAHİN A., YERLİKAYA F., VURAL İ., ÇAPAN Y.

American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition 2014, 02 Kasım 2014, (Özet Bildiri)

31. Inhibition Of Microbial Leakage at İmplant-Abutment İnterface with Chitosan Gels

TOKTAŞ S., ÇOPUROĞLU S., Erdoğdu C., ŞAHİN A., SAĞIROĞLU M., ÇAPAN Y., et al.

American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition 2014, 02 Kasım 2014, (Özet Bildiri)

32. A Pharmacy in James Joyce’s Ulysses: The Sweny’s Pharmacy-James Joyce’un Ulysses Eserinde Bir Eczane: Sweny’nin Eczanesi

ŞAHİN A.

XI. National Conference on the History of Turkish Pharmacy, Kayseri, Türkiye, 25 - 28 Mayıs 2014, (Özet Bildiri)

Kitaplar 7

7. Regulatory Guidelines of the US Food and Drug Administration and the European Medicines Agency for Actively Targeted Nanomedicines

Çetintaş H. C., TONBUL H., ŞAHİN A., ÇAPAN Y.

Drug Delivery with Targeted Nanoparticles: In Vitro and in Vivo Evaluation Methods, Taylor & Francis Ltd, ss.725-741, 2021

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (Scopus)

535

H-İndeks (Scopus)

Fikri Mülkiyet

Tez Danışmanlığı

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (Scopus)

H-İndeks (Scopus)

Fikri Mülkiyet

Tez Danışmanlığı

Açık Erişim